10 Takeover Targets of 2016
Which Biopharmas Do Wall Street Watchers View As Top Buyout Candidates?
Molecular Dx Has Your (Copy) Number
CNV Detection and Analysis Tools Are Being Used To Fill Genetic Diagnostic Gaps
Humanizing Animals for Immuno-Oncology
Success in Humanizing Mice Has Inspired Similar Efforts in Rats, Pigs, and Other Animals
Transcript-Savvy Discovery Is a Smart Bet
Drug Developers Are Finding Ways to Bend the Transcriptome to Their Will
For full access to this article login to GEN Select now.
CMOs Aim to Boost Production Efficiency
Capacity, Compliance, and Quality Remain the Keystones for Success in Biomanufacturing Operations
- Laureate Pharma (www.laureatepharma.com)recently signed an agreement with LPath (www.lpath.com) to manufacture Sphingomab™, Lpath’s lipid-specific humanized Mab. Laureate will provide the full-scale development of this product for clinical trials, including cell-line development, optimization, upstream and downstream development, and final cGMP manufacture. “We strive to combine biomanufacturing expertise with flexibility ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.